Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
Stock Snapshot
The current Illumina(ILMN) stock price is $120.67, with a market capitalization of 18.45B. The stock trades at a price-to-earnings (P/E) ratio of 27.03.
During the trading session on 2025-11-15, Illumina(ILMN) shares reached a daily high of $121.50 and a low of $117.09. At a current price of $120.67, the stock is +3.1% higher than the low and still -0.7% under the high.
Trading volume for Illumina(ILMN) stock has reached 1.06M, versus its average volume of 1.9M.
The stock's 52-week range extends from a low of $68.70 to a high of $153.06.
The stock's 52-week range extends from a low of $68.70 to a high of $153.06.
ILMN News
Illumina (ILMN) is back in the spotlight after the publication of a groundbreaking whole-genome sequencing study in Nature and the Chinese export ban on its pro...
Ever wondered if Illumina could be a hidden gem, potentially undervalued and offering an opportunity that others might be missing? Despite a recent 29.0% surge...
The Chinese Ministry of Commerce has lifted the export ban on Illumina, Inc., allowing the company to resume shipments to China as of today, although Illumina r...
Analyst ratings
48%
of 23 ratingsMore ILMN News
Piper Sandler raised the firm’s price target on Illumina (ILMN) to $195 from $185 following quarterly results. The firm keeps an Overweight rating on the shares...